4,205 results match your criteria Archives Of Pharmacal Research[Journal]


Three new ent-abietane diterpenoids from the roots of Euphorbia fischeriana and their cytotoxicity in human tumor cell lines.

Arch Pharm Res 2019 Apr 17. Epub 2019 Apr 17.

Department of Pharmacy, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, People's Republic of China.

Three new ent-abietane diterpenoids, termed fischerianoids A-C (1-3), were isolated and identified from the ethyl acetate extracts of roots of the medicinally valuable plant Euphorbia fischeriana. The planar and relative structures of 1-3 were established via high-resolution electrospray ionisation mass spectrometry and one- and two-dimensional nuclear magnetic resonance spectroscopic analyses, and the absolute configuration of 1 was further established via X-ray crystallography experiment. Compounds 1-3 showed selective inhibitory potency against certain human tumor cell lines with IC values ranging from 8. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01151-yDOI Listing

Green synthesis and biological activities of silver nanoparticles prepared by Carpesium cernuum extract.

Arch Pharm Res 2019 Apr 10. Epub 2019 Apr 10.

College of Pharmacy and Inje Institute of Pharmaceutical Sciences and Research, Inje University, 197 Inje-ro, Gimhae, Gyeongnam, 50834, Republic of Korea.

The extract of Carpesium cernuum whole plant was successfully used as a green factory for the synthesis of silver nanoparticles in a one-step, one-pot process. The extract efficiently reduced silver ions to spherical silver nanoparticles. The size was measured as 13. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01152-xDOI Listing
April 2019
1 Read

Natural compound inducers of immunogenic cell death.

Authors:
Marc Diederich

Arch Pharm Res 2019 Apr 6. Epub 2019 Apr 6.

Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Building 29 Room 223, 1 Gwanak-ro, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, South Korea.

Accumulating evidence shows that the anti-cancer potential of the immune response that can be activated by modulation of the immunogenicity of dying cancer cells. This regulated cell death process is called immunogenic cell death (ICD) and constitutes a new innovating anti-cancer strategy with immune-modulatory potential thanks to the release of damage-associated molecular patterns (DAMPs). Some conventional clinically-used chemotherapeutic drugs, as well as preclinically-investigated compounds of natural origins such as anthracyclines, microtubule-destabilizing agents, cardiac glycosides or hypericin derivatives, possess such an immune-stimulatory function by triggering ICD. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01150-zDOI Listing
April 2019
1 Read

T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.

Authors:
Seon Hee Chang

Arch Pharm Res 2019 Apr 2. Epub 2019 Apr 2.

Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

Th17 cells are a specialized subset of CD4+ T cells that are essential in driving inflammation during autoimmune disease and infection through a signature cytokine IL-17. Th17 cells have been found in various human cancers. The function of these cells in cancers is highly context-dependent; both tumor-promoting and tumor-suppressing activity have been reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01146-9DOI Listing
April 2019
1 Read

Transendothelial migration (TEM) of in vitro generated dendritic cell vaccine in cancer immunotherapy.

Arch Pharm Res 2019 Apr 1. Epub 2019 Apr 1.

Department of Biological Sciences, Science Research Center (SRC) for Immune Research on Non-lymphoid Organ (CIRNO), Sungkyunkwan University, Jangan-gu, Suwon, Gyeonggi-do, 16419, South Korea.

Many efforts have been made to improve the efficacy of dendritic cell (DC) vaccines in DC-based cancer immunotherapy. One of these efforts is to deliver a DC vaccine more efficiently to the regional lymph nodes (rLNs) to induce stronger anti-tumor immunity. Together with chemotaxis, transendothelial migration (TEM) is believed to be a critical and indispensable step for DC vaccine migration to the rLNs after administration. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-019-01145-w
Publisher Site
http://dx.doi.org/10.1007/s12272-019-01145-wDOI Listing
April 2019
1 Read

Autophagy at synapses in neurodegenerative diseases.

Arch Pharm Res 2019 Apr 1. Epub 2019 Apr 1.

Department of Physiology, School of Medicine, Kyung Hee University, Seoul, 02447, South Korea.

Autophagy is an essential process for maintaining cellular homeostasis, a critical process in all cell types. Because neurons are post-mitotic cells, maintaining cellular and functional homeostasis is more important in neurons than in other types of cells. Synapses are fundamental units needed for neural communication, and synapses with consistent protein quality are essential for neural functionality. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01148-7DOI Listing
April 2019
1 Read

Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases.

Authors:
Dong-Hoon Hyun

Arch Pharm Res 2019 Mar 27. Epub 2019 Mar 27.

Department of Life Science, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 03760, South Korea.

Mitochondrial dysfunction caused by oxidative stress appears at early stages of aging and age-related diseases. Plasma membrane redox enzymes act in a compensatory manner to decrease oxidative stress and supply reductive capacity to ensure cell survival. Plasma membrane redox enzymes transfer electrons from NAD(P)H to oxidized ubiquinone and α-tocopherol, resulting in inhibition of further oxidative damage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01147-8DOI Listing

The fungus Colletotrichum as a source for bioactive secondary metabolites.

Arch Pharm Res 2019 Mar 26. Epub 2019 Mar 26.

College of Pharmacy and Innovative Drug Center, Duksung Women's University, Seoul, 01369, Republic of Korea.

Colletotrichum sp. is a widely distributed fungal genus, which is mainly known to cause anthracnose on cereals, legumes, fruit trees, and vegetables. Even though many of the Colletotrichum sp. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01142-zDOI Listing

Role of hydrogen sulfide in cerebrovascular alteration during aging.

Arch Pharm Res 2019 Mar 21. Epub 2019 Mar 21.

Department of Anatomy and Neurobiology, Graduate School, School of Medicine, Biomedical Science Institute, Kyung Hee University, Seoul, 02447, Republic of Korea.

Hydrogen sulfide (HS), a gasotransmitter molecule, has attracted attention as an endogenous signaling molecule because of its various pathological and physiological effects, including pathologies related to aging. In this review, we aimed to discuss the morphological changes in each vessel following aging, and to evaluate the possible role of HS in the cerebrovascular alteration, such as arterial stiffness, microvessel loss, and blood-brain barrier disruption, with advancing age. Additionally, the review outlines the therapeutic efficacy of the HS-releasing compounds on the cerebrovasculature. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01135-yDOI Listing

Natural killer cells as a promising therapeutic target for cancer immunotherapy.

Arch Pharm Res 2019 Mar 20. Epub 2019 Mar 20.

Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

Natural killer (NK) cells are innate lymphoid cells that provide early protection against cancer development via their selectivity to kill abnormal cells undergoing cellular transformation without the need for prior stimulation. Given the correlation between NK cell dysfunction and cancer prognosis, restoration of endogenous NK cells in the tumor microenvironment or adoptive transfer of NK cells with improved function holds great promise in cancer treatment. Furthermore, MHC-unrestricted tumor lysis by NK cells complements the MHC-restricted killing of tumor cells by cytotoxic T cells, thus positioning NK cells as an alternative or complementary therapeutic target for cancers that are refractory to T cell-based therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01143-yDOI Listing
March 2019
1 Read
1.751 Impact Factor

Induction of p53-mediated senescence is essential for the eventual anticancer therapeutic effect of RH1.

Arch Pharm Res 2019 Mar 16. Epub 2019 Mar 16.

Institute for Innovative Cancer Research, Asan Medical Center, Seoul, 05505, Korea.

RH1 (2, 5-diaziridinyl-3-(hydroxymethy)-6-methyl-1, 4-benzoquinone) is a bioreductive anticancer drug. The mechanism underlying its therapeutic properties has not yet been elucidated. In this study, we aimed to determine whether RH1 exerts its anticancer effect via p53-mediated apoptosis and senescence in vitro and in vivo. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01132-1DOI Listing
March 2019
3 Reads

Cell signaling and biological pathway in cardiovascular diseases.

Arch Pharm Res 2019 Mar 15;42(3):195-205. Epub 2019 Mar 15.

National Research Laboratory for Stem Cell Niche, Center for Medical Innovation, Seoul National University Hospital, Seoul, 110-744, Republic of Korea.

Currently, coronary artery disease accounts for a large proportion of deaths occurring worldwide. Damage to the heart muscle over a short period of time leads to myocardial infarction (MI). The biological mechanisms of atherosclerosis, one of the causes of MI, have been well studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01141-0DOI Listing

Preface for the special issue on recent advances and future perspectives of new drug development and therapeutics on cardiovascular diseases.

Authors:
You Mie Lee

Arch Pharm Res 2019 03;42(3):193-194

Lab of Vascular Homeostasis Regulation, Molecular Pathophysiology, College of Pharmacy, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu, 41566, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01144-xDOI Listing

Roles of NKT cells in cancer immunotherapy.

Arch Pharm Res 2019 Mar 11. Epub 2019 Mar 11.

Laboratory of Immunology, Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul, 08826, Republic of Korea.

Cancer immunotherapy has emerged as an effective therapeutic strategy to treat cancer. Among diverse immune populations, invariant natural killer T (iNKT) cells have shown potent antitumor activity by linking innate and adaptive immune systems. Upon activation by lipid antigens on CD1d molecules, iNKT cells rapidly produce various cytokines and trigger antitumor immunity directly or indirectly by activating other antitumor immune cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01139-8DOI Listing
March 2019
1 Read

Differential effect of LPS and paclitaxel on microglial functional phenotypes and circulating cytokines: the possible role of CX3CR1 and IL-4/10 in blocking persistent inflammation.

Arch Pharm Res 2019 Mar 9. Epub 2019 Mar 9.

Department of Pharmacology, School of Medicine, CHA University, CHA Bio Complex, 335 Pangyo, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.

Neuroinflammation plays a role in cancer chemotherapy-induced chronic pain. Thus far, most studies have focused on neuroinflammation suppression. However, there are limited reports of which factor is involved in the transition from acute inflammation to chronic inflammation, resulting in neuroinflammation and chronic pain. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01137-wDOI Listing
March 2019
1 Read

Immunological and clinical implications of immune checkpoint blockade in human cancer.

Arch Pharm Res 2019 Mar 6. Epub 2019 Mar 6.

Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.

Immune checkpoint inhibitors (ICIs) such as anti-PD-1 and anti-CTLA-4 therapy are now FDA-approved treatment options for different cancer types. However, the therapeutic efficacy of ICIs varies substantially among cancer types and patients, and only a limited proportion of cancer patients benefit clinically from ICIs. To improve the therapeutic efficacy of cancer treatments involving ICI, the mechanisms of response to ICIs and the heterogeneous pattern of immune checkpoint receptor expression need to be better understood. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01140-1DOI Listing
March 2019
1 Read

Palmitoylation-mediated synaptic regulation of AMPA receptor trafficking and function.

Arch Pharm Res 2019 Mar 5. Epub 2019 Mar 5.

Center for Functional Connectomics, Brain Science Institute, Korea Institute of Science and Technology, Seoul, 02792, South Korea.

The α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a major glutamate-gated ion channel in the brain and is important for synaptic transmission, synaptic plasticity, and learning. Palmitoylation, a post-translational modification, is a critical process regulating AMPAR trafficking, synaptic function and plasticity, and learning and memory in health and diseases. In this review, we discuss current knowledge on the palmitoylation-dependent regulation of AMPAR trafficking and functions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01134-zDOI Listing

Hypothalamic inflammation and obesity: a mechanistic review.

Arch Pharm Res 2019 Mar 5. Epub 2019 Mar 5.

Department of Oral Biology, Yonsei University College of Dentistry, BK21 PLUS, Seoul, 03722, Korea.

Obesity is one of the worldwide prevalent disease caused by the imbalance between food intake and energy expenditure. Over a 100 years of research demonstrate that hypothalamus is the critical brain region regulating energy homeostasis, and evidences suggest the participation of non-neuronal populations such as astrocytes and microglia in the regulation of energy homeostasis. Recently, fat-rich diet induced hypothalamic inflammation has been found to deregulate the energy homeostasis, leading to the insulin resistance, glucose intolerance, and obesity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01138-9DOI Listing
March 2019
1 Read

Evolution of chimeric antigen receptor (CAR) T cell therapy: current status and future perspectives.

Arch Pharm Res 2019 Mar 4. Epub 2019 Mar 4.

Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, 34141, Republic of Korea.

Engineering T cells with a chimeric antigen receptor (CAR) that reprograms their antigen selectivity and signaling has recently emerged as one of the most promising therapeutic approaches for treating cancers. For example, two CD19-specific CAR T cell (CAR-T) therapies have shown remarkable responses in patients with relapsed/refractory B-cell cancers, and were approved by the US Food and Drug Administration in 2017. This initial clinical success has spurred an explosion of interests in this novel therapy from both academia and industry, and results from basic and clinical research have enabled the rapid evolution of the CAR-T field. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-019-01136-x
Publisher Site
http://dx.doi.org/10.1007/s12272-019-01136-xDOI Listing
March 2019
16 Reads

Significant roles of neuroinflammation in Parkinson's disease: therapeutic targets for PD prevention.

Arch Pharm Res 2019 Mar 4. Epub 2019 Mar 4.

Department of Pharmacy, College of Pharmacy, Pusan National University, Busan, 46241, Republic of Korea.

Glial cells outnumber neurons in the brain and play important roles in the neuroinflammation that accompanies brain damage in neurodegenerative diseases. In Parkinson's disease (PD), dopaminergic neuronal loss is accompanied by inflammatory changes in microglia, astrocytes, innate immune cells, and infiltrating peripheral immune cells. Neuroinflammation is probably a fundamental immune response to protect neurons from harm and compensate for neuronal damage, but at the same time, its neurotoxic effects exacerbate neuron damage. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01133-0DOI Listing
March 2019
3 Reads

Targeting epigenetics for cancer therapy.

Arch Pharm Res 2019 Feb 26;42(2):159-170. Epub 2019 Feb 26.

Research Center for Epigenome Regulation, School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.

Cancer can be identified as a chaotic cell state, which breaks the rules that govern growth and reproduction, with main characteristics such as uncontrolled division, invading other tissues, usurping resources, and eventually killing its host. It was once believed that cancer is caused by a progressive series of genetic aberrations, and certain mutations of genes, including oncogenes and tumor suppressor genes, have been identified as the cause of cancer. However, piling evidence suggests that epigenetic modifications working in concert with genetic mechanisms to regulate transcriptional activity are dysregulated in many diseases, including cancer. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01126-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399185PMC
February 2019

Recent advances in the pathogenesis of microvascular complications in diabetes.

Arch Pharm Res 2019 Mar 15;42(3):252-262. Epub 2019 Feb 15.

Leading-Edge Research Center for Drug Discovery and Development for Diabetes and Metabolic Disease, Kyungpook National University Hospital, Daegu, South Korea.

Millions of people worldwide have diabetes, which is diagnosed by fasting blood glucose levels exceeding 126 mg/dL. Regardless of the type of diabetes, prolonged hyperglycemia is damaging to several organs including eyes, kidneys, nerve, and/or heart. The damages are associated with a high risk of morbidity and mortality. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-019-01130-3
Publisher Site
http://dx.doi.org/10.1007/s12272-019-01130-3DOI Listing
March 2019
5 Reads

Mitochondria-centric bioenergetic characteristics in cancer stem-like cells.

Arch Pharm Res 2019 Feb 15;42(2):113-127. Epub 2019 Feb 15.

Department of Surgery, Yonsei University Health System, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, Korea.

Metabolic and genotoxic stresses that arise during tumor progression and anti-cancer treatment, respectively, can impose a selective pressure to promote cancer evolution in the tumor microenvironment. This process ultimately selects for the most "fit" clones, which generally have a cancer stem cell like phenotype with features of drug resistance, epithelial-mesenchymal transition, invasiveness, and high metastatic potential. From a bioenergetics perspective, these cancer stem-like cells (CSCs) exhibit mitochondria-centric energy metabolism and are capable of opportunistically utilizing available nutrients such as fatty acids to generate ATP and other metabolic substances, providing a selective advantage for their survival in an impermissible environment and metabolic context. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01127-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399179PMC
February 2019

Rab25 and RCP in cancer progression.

Arch Pharm Res 2019 Feb 14;42(2):101-112. Epub 2019 Feb 14.

Department of Pharmacology, College of Medicine, Konyang University, 821 Medical Science Building, 158 Gwanjeodong-ro, Seo-gu, Daejeon, 35365, Republic of Korea.

Cancer invasion and metastasis is the crucial cause of death for most cancer patients. Endosome recycling of receptors for growth factors and adhesion molecules to the plasma membrane prevents them from degradation at the inside of the lysosome and recapitulates their functions, leading to major causativeness of cancer progression. Rab25 belongs to Rab-GTPase family and implicated in cancer progression in a context-dependent manner. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01129-wDOI Listing
February 2019

Peptide-based targeted therapeutics and apoptosis imaging probes for cancer therapy.

Arch Pharm Res 2019 Feb 12;42(2):150-158. Epub 2019 Feb 12.

Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, 41944, Republic of Korea.

Peptides have advantages over antibodies in terms of deep tissue penetration, low immunogenicity, and cost-effective production, but they have short circulation time and poor stability in vivo. Peptides have been extensively used as targeting moieties for the delivery of drug-loaded nanoparticles and function as targeted therapeutics in cancer treatment. Here, we review peptides that are exploited as targeted therapeutics in cancer therapy and apoptosis imaging probes for the monitoring of treatment responses. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01125-0DOI Listing
February 2019
1 Read

In vivo imaging for neurovascular disease research.

Arch Pharm Res 2019 Mar 11;42(3):263-273. Epub 2019 Feb 11.

Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), 291 Daehak-ro, Yuseong-gu, Daejeon, 34141, Republic of Korea.

Connections between various cell types in the brain enable cognitive function. The neurovascular unit is a structure composed of different cell types that regulate neurovascular coupling, blood-brain barrier permeability, and other interactions with peripheral systems. The relationship among the components of the neurovascular unit is complex and difficult to study without the use of in vivo neurovascular disease imaging. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01128-xDOI Listing
March 2019
1.751 Impact Factor

Peroxisomal dysfunction in neurodegenerative diseases.

Arch Pharm Res 2019 Feb 9. Epub 2019 Feb 9.

School of Life Sciences, Kyungpook National University, 80 Daehakro Bukgu, Daegu, 41566, Republic of Korea.

Peroxisomes and their (patho-)physiological importance in heath and disease have attracted increasing interest during last few decades. Together with mitochondria, peroxisomes comprise key metabolic platforms for oxidation of various fatty acids and redox regulation. In addition, peroxisomes contribute to bile acid, cholesterol, and plasmalogen biosynthesis. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-019-01131-2
Publisher Site
http://dx.doi.org/10.1007/s12272-019-01131-2DOI Listing
February 2019
5 Reads

Current pharmacotherapies for atherosclerotic cardiovascular diseases.

Arch Pharm Res 2019 Mar 6;42(3):206-223. Epub 2019 Feb 6.

Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul, 120-750, Republic of Korea.

Despite the introduction of statins for lowering LDL-C level, atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of death and morbidity worldwide. Combination therapies with statin and other lipid-lowering drugs, including ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors, have unlocked additive benefits for treatment of ASCVD, but morbidity and mortality due to ASCVD remain high. New anti-inflammatory therapies have emerged for treatment and prevention of ASCVD to address these problems. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01116-1DOI Listing

Correction to: Identification of N-arylsulfonylpyrimidones as anticancer agents.

Arch Pharm Res 2019 Feb 6. Epub 2019 Feb 6.

College of Pharmacy and Institute of Drug Research and Development, Chungnam National University, Daejeon, 34134, Republic of Korea.

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: The authors declare no conflict of interest. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01121-4DOI Listing
February 2019
3 Reads

Correction to: Lifespan-extending property of 6-shogaol from Zingiber officinale Roscoe in Caenorhabditis elegans.

Arch Pharm Res 2019 Feb 6. Epub 2019 Feb 6.

College of Pharmacy, Woosuk University, Jeonju, 55338, Republic of Korea.

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: The authors declare no conflict of interest. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01119-yDOI Listing
February 2019

Correction to: Saroclazines A-C, thio-diketopiperazines from mangrove-derived fungi Sarocladium kiliense HDN11-84.

Arch Pharm Res 2019 Feb 6. Epub 2019 Feb 6.

Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, People's Republic of China.

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01112-5DOI Listing
February 2019
1.751 Impact Factor

Non-glycosidic iridoids from the roots of Patrinia scabra and their nitric oxide production inhibitory effects.

Arch Pharm Res 2019 Feb 5. Epub 2019 Feb 5.

Department of Life and Nanopharmaceutical Sciences, Graduate School, Kyung Hee University, Seoul, 02447, Republic of Korea.

Phytochemical investigation on the 70% aqueous EtOH extract from the roots of Patrinia scabra led to the isolation and characterization of five new non-glycosidic iridoids, patriscabrins F-J (1-5), along with a known iridoid 11-ethoxyviburtinal (6). The structures of the new compounds 1-5 were determined by interpretation of spectroscopic data, particularly by 1D- and 2D-NMR and ECD studies. Thereafter, the isolates 1-6 were evaluated for their inhibitory effects on lipopolysaccharide-induced nitric oxide production in RAW 264. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01117-0DOI Listing
February 2019

Retraction Note to: Analysis of loxoprofen in tablets, patches, and equine urine as tert-butyldimethylsilyl derivative by gas chromatography-mass spectrometry.

Arch Pharm Res 2019 02;42(2):191

College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Suncheon, 540-950, Republic of Korea.

The authors have retracted this article [1] because after publication they became aware that the equine urine samples analysed for loxoprofen in this study were in fact equine plasma samples. Therefore the results and conclusions of this article cannot be relied upon. All authors agree to this retraction. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01109-0DOI Listing
February 2019

Development of BTK inhibitors for the treatment of B-cell malignancies.

Authors:
Hyung-Ook Kim

Arch Pharm Res 2019 Feb 31;42(2):171-181. Epub 2019 Jan 31.

Department of Clinical Medicinal Sciences, Konyang University, 121 Daehakro, Nonsan, 32992, Republic of Korea.

BTK is a key component of B-cell receptor signaling and functions as an important regulator of cell proliferation and survival in B-cell malignancies. The first-in-class BTK inhibitor ibrutinib is a small molecule drug that binds covalently to BTK and has been proved to be an effective treatment for various B-cell malignancies. However, it has off-target activities on non-BTK kinases that are related to side effects or might be translated into clinical limitations, with resistance to ibrutinib also reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01124-1DOI Listing
February 2019

Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 as a molecular target in breast cancer: a therapeutic perspective of gynecological cancer.

Arch Pharm Res 2019 Feb 25;42(2):128-139. Epub 2019 Jan 25.

College of Pharmacy, Chosun University, 309 Philmundaero, Dong-gu, Gwangju, 61452, Republic of Korea.

Peptidyl-prolyl cis/trans isomerase NIMA-interacting 1 (PIN1) induces conformational and functional changes to numerous key signaling molecules following proline-directed phosphorylation and its deregulation contributes to disease, particularly cancer. PIN1 is overexpressed in breast cancer, promoting cell proliferation and transformation in collaboration with several oncogenic signaling pathways, and is correlated with a poor clinical outcome. PIN1 level is also increased in certain gynecological cancers such as cervical, ovarian, and endometrial cancers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01122-3DOI Listing
February 2019

Role of stem cell mobilization in the treatment of ischemic diseases.

Arch Pharm Res 2019 Mar 24;42(3):224-231. Epub 2019 Jan 24.

Department of Physiology, Pusan National University School of Medicine, Yangsan, 50612, Republic of Korea.

Stem cell mobilization plays important roles in the treatment of severe ischemic diseases, including myocardial infarction, limb ischemia, ischemic stroke, and acute kidney injury. Stem cell mobilization refers to the egress of heterogeneous stem cells residing in the bone marrow into the peripheral blood. In the clinic, granulocyte colony-stimulating factor (G-CSF) is the drug most commonly used to induce stem cell mobilization. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01123-2DOI Listing
March 2019
5 Reads

Diverse roles of noncoding RNAs in vascular calcification.

Arch Pharm Res 2019 Mar 23;42(3):244-251. Epub 2019 Jan 23.

Department of Pharmacology, Chonnam National University Medical School, Hwasun, Jeollanam-do, 58128, Republic of Korea.

Vascular calcification occurs when calcium phosphate crystals are abnormally deposited in the vessel walls, thus hardening and narrowing the arteries. This condition is commonly observed in patients with diseases such as atherosclerosis, chronic kidney disease, diabetes, and cardiovascular diseases. Despite many studies being conducted, the molecular mechanism involved in vascular calcification is unknown. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01118-zDOI Listing

Acid ceramidase, an emerging target for anti-cancer and anti-angiogenesis.

Arch Pharm Res 2019 Mar 19;42(3):232-243. Epub 2019 Jan 19.

Chemical Genomics Global Research Laboratory, Department of Biotechnology, College of Life Science & Biotechnology, Yonsei University, Seoul, 120-749, Republic of Korea.

Sphingolipid metabolism plays an important role in determining the fate of a cell. Among several sphingolipid metabolites, ceramide is a key player in intracellular signal transduction. Ceramide is usually converted to various metabolites such as sphingomyelin, sphingosine, ceramide-1-phosphate, and glucosylceramide. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01114-3DOI Listing
March 2019
2 Reads

Targeting cancer energy metabolism: a potential systemic cure for cancer.

Authors:
Soo-Youl Kim

Arch Pharm Res 2019 Feb 17;42(2):140-149. Epub 2019 Jan 17.

Tumor Microenvironment Research Branch, Division of Basic Science, Research Institute, National Cancer Center, Goyang, Gyonggi-do, Republic of Korea.

Long-term investigation and extensive efforts using sequencing and -omics analysis identified thousands of mutations in a single tumor. However, we cannot succeed at curing cancer by targeting mutations as the cause of cancer. Therefore, as an alternate therapeutic approach from classical oncology study, stimulation of the inherent ability of the immune system to attack tumor cells was welcome as a new principle in cancer therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-019-01115-2DOI Listing
February 2019

Therapeutic implications of cancer epithelial-mesenchymal transition (EMT).

Arch Pharm Res 2019 Jan 16;42(1):14-24. Epub 2019 Jan 16.

Department of Oral Pathology, Oral Cancer Research Institute, Yonsei University College of Dentistry, Seoul, 03722, Republic of Korea.

The epithelial-mesenchymal transition (EMT) comprises an essential biological process involving cancer progression as well as initiation. While the EMT has been regarded as a phenotypic conversion from epithelial to mesenchymal cells, recent evidence indicates that it plays a critical role in stemness, metabolic reprogramming, immune evasion and therapeutic resistance of cancer cells. Interestingly, several transcriptional repressors including Snail (SNAI1), Slug (SNAI2) and the ZEB family constitute key players for EMT in cancer as well as in the developmental process. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-018-01108-7
Publisher Site
http://dx.doi.org/10.1007/s12272-018-01108-7DOI Listing
January 2019
6 Reads

Correction to: Dihydroxanthyletin-type coumarins from Angelica decursiva that inhibits the formation of advanced glycation end products and human recombinant aldose reductase.

Arch Pharm Res 2019 Jan 12. Epub 2019 Jan 12.

Department of Food and Life Science, Pukyong National University, Busan, 48513, Republic of Korea.

The author would like to include conflict of interest statement of the online published article. The correct conflict of interest statement should read as: Conflict of interest The authors declare no conflict of interest. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-019-01113-4
Publisher Site
http://dx.doi.org/10.1007/s12272-019-01113-4DOI Listing
January 2019
1 Read
1.751 Impact Factor

Correction to: Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study.

Arch Pharm Res 2019 Jan 12. Epub 2019 Jan 12.

College of Pharmacy, Keimyung University, 1095 Dalgubeoldaero, Dalseo-gu, Daegu, 42601, Republic of Korea.

In the original version of the article titled "Development of a column-switching LC-MS/MS method of tramadol and its metabolites in hair and application to a pharmacogenetic study", published in 41(5):554-563 (https://doi.org/10.1007/s12272-018-1013-7), unfortunately an important statement was missing in the Clinical study section by the author. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-01105-wDOI Listing
January 2019
1 Read

Elucidation for modulation of death receptor (DR) 5 to strengthen apoptotic signals in cancer cells.

Arch Pharm Res 2019 Jan 10;42(1):88-100. Epub 2019 Jan 10.

Department of Immunology, School of Medicine, Keimyung University, 2800 Dalgubeoldaero, Dalseo-Gu, Daegu, 704-701, Korea.

The tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces apoptosis via death receptor (DR) 4 or DR5 preferentially in cancer cells, and not in normal cells with relatively high decoy receptor expression. However, multiple mechanisms in cancer cells induce resistance to DRs-mediated apoptosis. Therefore, understanding of molecular mechanisms for resistance to DRs-mediated apoptosis can find the strategy to increase sensitivity. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-01103-yDOI Listing
January 2019

Correction to: Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid.

Arch Pharm Res 2019 Jan 10. Epub 2019 Jan 10.

College of Pharmacy, Keimyung University, 1095 Dalgubeoldaero, Dalseo-gu, Daegu, 42601, Republic of Korea.

In the original version of the article titled "Development of a linear dual column HPLC-MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid", published in 41(3):288-298 ( https://doi.org/10.1007/s12272-017-0993-z ), unfortunately an important statement was missing in the Clinical study section by the author. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-01106-9DOI Listing
January 2019
1 Read

Post-translational modification of the death receptor complex as a potential therapeutic target in cancer.

Arch Pharm Res 2019 Jan 4;42(1):76-87. Epub 2019 Jan 4.

Department of Pharmacology and Department of Medical Science, College of Medicine, Chungnam National University, Daejeon, 35015, Republic of Korea.

Programmed cell death is critical to the physiological function of multi-cellular organisms, controlling development, immunity, inflammation, and cancer progression. Death receptor (DR)-mediated regulation of a protease functions as a second messenger to initiate a death signal cascade to induce apoptosis or necroptosis. Recently, it has become clear that post-translational modifications (PTMs) of signaling components in the DR complex are highly complex, temporally controlled, and tightly regulated, and play an important role in cell death signaling. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-018-01107-8
Publisher Site
http://dx.doi.org/10.1007/s12272-018-01107-8DOI Listing
January 2019
10 Reads

Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.

Arch Pharm Res 2019 Jan 4;42(1):48-62. Epub 2019 Jan 4.

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanakro, Seoul, 08826, South Korea.

Hepatocellular carcinoma (HCC) is a tumor with poor prognosis and frequently aggressive. The development of HCC is associated with fibrosis and cirrhosis, which mainly results from nonalcoholic fatty liver disease, excessive alcohol consumption, and viral infections. Non-coding RNAs (ncRNAs) are RNAs transcribed from the genome, but are not translated into proteins. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-01104-xDOI Listing
January 2019

Lignans from Saururus chinensis exhibit anti-inflammatory activity by influencing the Nrf2/HO-1 activation pathway.

Arch Pharm Res 2019 Jan 4. Epub 2019 Jan 4.

College of Pharmacy, Drug Research and Development Center, Daegu Catholic University, Gyeongbuk, 712-702, Republic of Korea.

As part of our ongoing program to develop anti-inflammatory agents, an extract derived from Saururus chinensis collected in Korea was found to inhibit nitric oxide (NO) production in RAW264.7 cells. Bioassay-guided fractionation led to the isolation two new (1 and 2) and six known dineolignans (3-8). Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-018-1093-4
Publisher Site
http://dx.doi.org/10.1007/s12272-018-1093-4DOI Listing
January 2019
14 Reads

Tumor endothelial cells as a potential target of metronomic chemotherapy.

Arch Pharm Res 2019 Jan 2;42(1):1-13. Epub 2019 Jan 2.

Department of Molecular and Cellular Biochemistry School of Medicine, Kangwon National University School of Medicine, Chuncheon, Gangwon-do, 24341, South Korea.

Drug resistance and toxic side effects are major therapeutic hurdles affecting cancer patients receiving conventional chemotherapy based on the maximum tolerated dose. Metronomic chemotherapy (MCT), a new therapeutic approach developed to avoid these problems generally, consists of the continuous administration of low-dose cytotoxic agents without extended intervals. This therapy targets the tumor microenvironment, rather than exerting a direct effect on tumor cells. Read More

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12272-018-01102-z
Publisher Site
http://dx.doi.org/10.1007/s12272-018-01102-zDOI Listing
January 2019
14 Reads

Multifaceted C-terminus of HSP70-interacting protein regulates tumorigenesis via protein quality control.

Arch Pharm Res 2019 Jan 1;42(1):63-75. Epub 2019 Jan 1.

Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Korea.

C-terminus of heat shock protein 70 (HSP70)-interacting protein (CHIP) is an E3 ligase involved in a variety of protein homeostasis events implicated in diverse signaling pathways. Its involvement in varied and even opposite signaling circuits might be due to its hallmark signature of associating with molecular chaperones, including HSP90 and HSP70. Together, these proteins may be pivotal in implementing protein quality control. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-1101-8DOI Listing
January 2019

Roles of folate in skeletal muscle cell development and functions.

Arch Pharm Res 2019 Jan 1. Epub 2019 Jan 1.

Department of Pharmacy, Molecular Inflammation Research Center for Aging Intervention, College of Pharmacy, Pusan National University, 63beon-gil 2, Geumjeong-gu, Busan, 46241, Republic of Korea.

Folate is the generic term for both naturally occurring food folate and folic acid, the fully oxidized monoglutamate form of the vitamin that is used in dietary supplements and fortified foods. It is a water-soluble vitamin B9 and is important for health, growth, and development. As a precursor of various cofactors, folate is required for one-carbon donors in the synthesis of DNA bases and other essential biomolecules. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12272-018-1100-9DOI Listing
January 2019
1 Read